Autolus Therapeutics (AUTL) Change in Receivables (2025)
Autolus Therapeutics' (AUTL) quarterly Change in Receivables came in at -$8.6 million in Q4 2025, down 242.79% on a QoQ basis from $6.0 million in Q3 2025.
Powered by 
Analysis
Autolus Therapeutics (AUTL) Change in Receivables (2025) Analysis & Trends
Autolus Therapeutics (AUTL) has 1 years of Change in Receivables data on file, last reported at -$8.6 million in Q4 2025.
- Quarterly Change in Receivables changed N/A year-over-year to -$8.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $24.2 million (changed N/A YoY) and the FY2025 annual result came in at $24.2 million, changed N/A from the prior year.
- Change in Receivables retreated to -$8.6 million in Q4 2025, from $6.0 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $14.3 million in Q1 2025 to a low of -$8.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -53.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 117.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 31.60 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Autolus Therapeutics | 594.86 Mn | 393.23 Mn | 25.22 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -8.57 Mn |
| Sep 30, 2025 | 6.00 Mn |
| Jun 30, 2025 | 12.39 Mn |
| Mar 31, 2025 | 14.34 Mn |